This almanac highlights about 50 papers on heart failure in the major cardiac journals, including the current evidence base for traditional and novel treatment options: pharmacological (relaxin, levosimendan, neprilysin inhibitors, ivabradine. aliskiren, aldosterone antagonists) and devices (defibrillators, vagal stimulators etc.).
Full article | ![]() |